Target intelligence / Profile preview

Influenza A Hemagglutinin Antigen H3N2 Subtype (HA H3N2)

Target
HA H3N2
Molecular classification
Viral Protein, Glycoprotein, Membrane protein
01

Overview

The hemagglutinin (HA) antigen of the Influenza A virus, specifically the H3N2 subtype, is a trimeric glycoprotein found on the viral envelope. It is essential for viral infectivity, mediating binding to host cell receptors (sialic acids) and membrane fusion. HA is a major target for neutralizing antibodies, and its antigenic sites undergo frequent mutations (antigenic drift), necessitating regular updates to influenza vaccines. The H3N2 subtype is a significant cause of seasonal influenza epidemics.

Other names
H3N2 HemagglutininHA protein H3N2H3 HemagglutininInfluenza A/H3N2 Hemagglutinin
02

Mechanism of action

Neutralizing antibodies bind to HA, preventing receptor binding and/or membrane fusion. Neuraminidase inhibitors prevent the release of newly formed virus, indirectly impacting the spread of infection.

03

Biological functions

Receptor bindingMembrane fusionViral entryAntigen presentationImmune response elicitation
04

Disease associations

InfectionInfluenzaRespiratory diseaseEpidemicPandemic (potential)
05

Safety considerations

Antigenic drift leading to vaccine mismatchPotential for antibody-dependent enhancement (ADE) in some contextsEmergence of drug-resistant strains
06

Interacting drugs

Monoclonal antibodies (e.g., neutralizing antibodies targeting HA)

1 more in the full profile.

07

Biomarkers

HA antibody titers (for vaccine efficacy)HA sequence variations (for monitoring antigenic drift)

Beyond the preview

Go deeper on Influenza A Hemagglutinin Antigen H3N2 Subtype (HA H3N2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A Hemagglutinin Antigen H3N2 Subtype (HA H3N2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call